Concepedia

Hassiba Chaib-Mezrag

HC

Statistics

Publications

4

Citations

122

H-Index

4

Active since

2014

Affiliations

University of Kansas Medical Center(Current)

Hassiba Chaib-Mezrag is an author at University of Kansas Medical Center specializing in oncology, molecular oncology, and adult t-cell leukemia-lymphoma.

Publications per year

2014–2018

4

Publications

4

Small PARP inhibitor PJ-34 induces cell cycle arrest and apoptosis of adult T-cell leukemia cells

Xue Bai, Ramona Moles, Hassiba Chaib-Mezrag et al. · Journal of Hematology & Oncology · 2015 · 35 citations · Full text

, , +16

Tax impairs DNA replication forks and increases DNA breaks in specific oncogenic genome regions

Hassiba Chaib-Mezrag, Delphine Lemaçon, Hélène Fontaine et al. · Molecular Cancer · 2014 · 34 citations · Full text

, , +15

WRN-targeted therapy using inhibitors NSC 19630 and NSC 617145 induce apoptosis in HTLV-1-transformed adult T-cell leukemia cells

Ramona Moles, Xuetao Bai, Hassiba Chaib-Mezrag et al. · Journal of Hematology & Oncology · 2016 · 31 citations · Full text

, , +16

JAG1 overexpression contributes to Notch1 signaling and the migration of HTLV-1-transformed ATL cells

Marcia Bellon, Ramona Moles, Hassiba Chaib-Mezrag et al. · Journal of Hematology & Oncology · 2018 · 22 citations · Full text

, , +16

1–4 of 4